Delivery Order SPE2DB20D1004-SPE2DB23FG3C5
Award Date
8/1/23
Potential Completion Date
8/22/23
Potential Value
$1.9K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Cencora, Inc.
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The $1,963.54 firm fixed-price delivery order is for the supply of the TICOVAC 2.4 MCG/0.5 ML SYRINGE 0.5ML vaccine. The contract has an ultimate completion date of April 16, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,963.54, is a delivery order for the TICOVAC 2.4 MCG/0.5 ML SYRINGE 0.5ML vaccine product. The contract is a firm fixed-price arrangement with a performance period extending through May 7, 2025. This contract is not designated as a set-aside and was competitively awarded. Amerisourcebergen Drug...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,856.75, is a delivery order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. The IDC, worth up to $999,999,999.00, serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is for the delivery of TICOVAC 2.4 MCG/0.5 ML SYRINGE 0.5ML, a pharmaceutical product, to support the Medical Supply Chain of the Defense Logistics Agency (DLA). The $1,856.75 firm fixed price delivery order has a completion date of May 31, 2024 and was awarded on May 9, 2024. The contract is not designated with a set-aside. Amerisourcebergen, a major pharmaceutical distributor, holds a significant...
This federal contract award is for the delivery of TICOVAC 2.4 MCG/0.5 ML syringes to the Defense Logistics Agency (DLA). The $18,501.60 firm-fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a completion date of September 16, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,856.75 firm fixed-price delivery order is for the supply of TICOVAC 2.4 MCG/0.5 ML SYRINGE 0.5ML, a medical product, to support DLA's medical supply programs. The contract has no set-aside designation, indicating open competition. Amerisourcebergen also holds a $999,999,999 Indefinite Delivery Contract (IDC) with...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,564.64 Firm Fixed Price delivery order covers the procurement of TICOVAC 1.2 MCG/0.25 ML SYRING 0.25ML, a medical product. The contract has an ultimate completion date of March 18, 2025. This appears to be a delivery order under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. The contract, valued at $1,856.75, is for the delivery of TICOVAC 2.4 MCG/0.5 ML SYRINGE 0.5ML, a medical product, with a completion date of March 14, 2024. The award is not designated under any set-aside program. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which also holds a significant Indefinite...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $167,107.50 firm-fixed-price contract, with a performance period through July 2024, is for the supply of TICOVAC 2.4 MCG/0.5 ML SYRINGE 0.5ML, a vaccine product. The award does not have a set-aside designation, indicating open competition. AmerisourceBergen also holds a $999,999,999 Indefinite Delivery Contract (IDC) with...
This federal contract award is for the delivery of TICOVAC 1.2 MCG/0.25 ML SYRING 0.25ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The award, valued at $2,810.00, was made to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company. The contract has no set-aside designation, indicating it was awarded through full and open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with...